The Company A leading pharmaceutical company with offices, R&D laboratories, and manufacturing facilities across the globe. The Situation The company brought Cylance ® in just days after suffering a major data breach to evaluate the extent of the damage and perform a detailed threat assessment. Cylance’s Threat Research team quickly traced the initial infection to a family of advanced malware that had eluded the company’s existing endpoint security systems equipped with the latest signature updates. Soon after, Cylance team members joined forces with the company’s security operations team to eliminate every trace of the malware and remediate the infection. Although the company’s CISO was pleased with Cylance’s Threat Research team, he still questioned whether CylancePROTECT would

Join for free to read